WG
ALXN

Winton Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Winton Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,322
Closed -$978K – 1531
2021
Q2 		$978K Buy
5,322
+903
+20% +$155K 0.05% 541
2021
Q1 		$676K Buy
+4,419
New +$684K 0.04% 708
2020
Q4 		– Sell
-13,679
Closed -$1.56M – 1598
2020
Q3 		$1.56M Buy
13,679
+4,766
+53% +$514K 0.05% 643
2020
Q2 		$1M Buy
+8,913
New +$946K 0.03% 963
2017
Q4 		– Sell
-56,599
Closed -$7.94M – 725
2017
Q3 		$7.94M Buy
56,599
+54,164
+2,224% +$7.36M 0.25% 105
2017
Q2 		$296K Buy
+2,435
New +$283K 0.01% 568
2014
Q3 		– Sell
-16,703
Closed -$2.61M – 689
2014
Q2 		$2.61M Buy
+16,703
New +$2.64M 0.02% 426

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return